Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies

Massimiliano Berretta; Agnieszka Micek; Alessandra Lafranconi; Sabrina Rossetti; Raffaele Di Francia; Paolo De Paoli; Paola Rossi; Gaetano Facchini

doi:10.18632/oncotarget.24829

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies

Massimiliano Berretta _, Agnieszka Micek, Alessandra Lafranconi, Sabrina Rossetti, Raffaele Di Francia, Paolo De Paoli, Paola Rossi and Gaetano Facchini

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:20807-20815. https://doi.org/10.18632/oncotarget.24829

Metrics: PDF 1084 views | HTML 2114 views | ?

Abstract

Massimiliano Berretta1, Agnieszka Micek2, Alessandra Lafranconi3, Sabrina Rossetti4, Raffaele Di Francia5, Paolo De Paoli6, Paola Rossi7 and Gaetano Facchini4

1Department of Medical Oncology, National Cancer Institute-IRCCS, Aviano, Italy

2Department of Epidemiology and Population Studies, Jagiellonian University Medical College, Krakow, Poland

3The Research Centre on Public Health, University Milano-Bicocca, Milan, Italy

4Departmental Unit of Experimental Uro-Andrological Clinical Oncology, Department of Uro-Gynecological Oncology, Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, Naples, Italy

5Hematology-Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione G. Pascale IRCCS, Naples, Italy

6Scientific Directorate, National Cancer Institute, Aviano, Italy

7Department of Biology and Biotechnology, L. Spallanzani University of Pavia, Pavia, Italy

Correspondence to:

Massimiliano Berretta, email: [email protected]

Keywords: coffee; ovarian cancer; postmenopausal; meta-analysis; cohort studies

Received: February 07, 2018 Accepted: February 27, 2018 Published: April 17, 2018

ABSTRACT

Background: Coffee consumption has been associated with numerous cancers, but evidence on ovarian cancer risk is controversial. Therefore, we performed a meta-analysis on prospective cohort studies in order to review the evidence on coffee consumption and risk of ovarian cancer.

Methods: Studies were identified through searching the PubMed and MEDLINE databases up to March 2017. Risk estimates were retrieved from the studies, and dose-response analysis was modelled by using restricted cubic splines. Additionally, a stratified analysis by menopausal status was performed.

Results: A total of 8 studies were eligible for the dose-response meta-analysis. Studies included in the analysis comprised 787,076 participants and 3,541 ovarian cancer cases. The results showed that coffee intake was not associated with ovarian cancer risk (RR = 1.06, 95% CI: 0.89, 1.26). Stratified and subgroup analysis showed consisted results.

Conclusions: This comprehensive meta-analysis did not find evidence of an association between the consumption of coffee and risk of ovarian cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24829

Publication Alerts

Meta-Analysis:

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies

Abstract